KMX vs VNDA · P/E 19, rev $25.88B vs rev $102.2M
CarMax Inc (KMX) versus Vanda Pharmaceuticals Inc (VNDA) — a side-by-side from cached financials, not a winner call.
CarMax Inc (KMX) is a auto & truck dealerships company listed on US.
Vanda Pharmaceuticals Inc (VNDA) is a biotechnology company listed on NASDAQ.
Latest reported KMX revenue for 2026-02-28 was $25.88B. Net income was $247.3M. Revenue was down 1.8% from 2025-02-28 to 2026-02-28. KMX currently screens at market cap $10.26B and trailing P/E 18.9.
Latest reported VNDA revenue for 2026-06-30 was $102.2M. Net income was -$111.1M. Revenue was up 97.7% from 2026-03-31 to 2026-06-30. VNDA currently screens at market cap $358.4M.
KMX currently screens at market cap $10.26B and trailing P/E 18.9. VNDA currently screens at market cap $358.4M.
Not investment advice. Open the KMX and VNDA stock pages for the full models.
Not investment advice.